Ethics of regenerative medicine

The Googlization of health research



Consumer-oriented mobile technologies offer new ways of capturing multidimensional health data, and are increasingly seen as facilitators of medical research. This has opened the way for large consumer tech companies, like Apple, Google, Amazon and Facebook, to enter the space of health research, offering new methods for collecting, storing and analyzing health data.

While these developments are often portrayed as ‘disrupting’ research in beneficial ways, they also raise many ethical issues. These can be organized into three clusters: questions concerning the quality of research; privacy/informed consent; and new power asymmetries based on access to data and control over technological infrastructures. The author argues that this last cluster, insofar as it may affect future research agendas, deserves more critical attention.

SOURCE: Personalized Medicine

Dignity and enhancement

a dignified cat


Does human enhancement threaten our dignity as some prominent commentators have asserted? Or could our dignity perhaps be technologically enhanced?

After disentangling several different concepts of dignity, this essay focuses on the idea of dignity as a quality, a kind of excellence admitting of degrees and applicable to entities both within and without the human realm. I argue that dignity in this sense interacts with enhancement in complex ways which bring to light some fundamental issues in value theory, and that the effects of any given enhancement must be evaluated in its appropriate empirical context.

Yet it is possible that through enhancement we could become better able to appreciate and secure many forms of dignity that are overlooked or missing under current conditions. I also suggest that in a posthuman world, dignity as a quality could grow in importance as an organizing moral/aesthetic idea.

ESSAY: Nick Bostrom

Debate: Bill Andrews vs Craig Klugman

Molecular Biologist Dr. Bill Andrews PhD is featured in an episode of The Doctors where he debates Dr. Craig Klugman, a bioethicist. The topic explores anti-aging clinical trials, questions, and concerns from a panel of doctors and answers provided by Dr. Bill Andrews in this engaging discussion.